Agency Information Collection Activities: Proposed Collection; Comment Request, 20697 [E6-5833]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 77 / Friday, April 21, 2006 / Notices
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
Written comments and
recommendations for the proposed
information collections must be mailed
or faxed within 30 days of this notice
directly to the OMB desk officer: OMB
Human Resources and Housing Branch,
Attention: Carolyn Lovett, New
Executive Office Building, Room 10235,
Washington, DC 20503, Fax Number:
(202) 395–6974.
Dated: April 12, 2006.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E6–5832 Filed 4–20–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10193 and CMS–
10133]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New Collection; Title of
Information Collection: Medicare
Clinical Laboratory Services
Competitive Bidding Demonstration
Project—Bidding Form; Use: The
Medicare Clinical Laboratory
Competitive Bidding Demonstration is
mandated by section 302(b) of the
rwilkins on PROD1PC63 with NOTICES
AGENCY:
VerDate Aug<31>2005
17:21 Apr 20, 2006
Jkt 208001
Medicare Prescription Drug,
Improvement and Modernization Act
(MMA) of 2003. The purpose of the
demonstration is to determine whether
competitive bidding can be used to
provide quality laboratory services at
prices below current Medicare
reimbursement rates. The application is
to collect information from
organizations that supply clinical
laboratory services to Medicare
beneficiaries in the Competitive Bidding
Area (CBA). This information will be
used to determine bidding status,
winners under the bidding competition,
and the competitively-determined fee
schedule for demonstration tests. The
winning laboratories will be selected
based on multiple criteria, including
price bid, laboratory capacity, service
area, and quality. Multiple winners are
expected in each competitive
acquisition areas; Form Number: CMS–
10193 (OMB#: 0938–New); Frequency:
Reporting—Other: Once every three
years; Affected Public: Business or other
for-profit; Number of Respondents: 80;
Total Annual Responses: 80; Total
Annual Hours: 7010.
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Competitive
Acquisition Program (CAP) for Medicare
Part B Drugs: Vendor Application and
Bid Form; Use: The CAP Vendor
Application and Bid Form is a
collection tool which will be used by
potential vendors to provide
information related to the characteristics
of their company and to submit their bid
prices for CAP drugs. The information
collected on the CAP Vendor
Application and Bid Form will be used
by CMS during the bidding evaluation
process to evaluate the vendors bid
prices, their credentials, experience and
to assess their ability to provide quality
service to physicians and beneficiaries.
Competitive bidding is seen as a means
of using the dynamics of the
marketplace to provide incentives for
suppliers to provide reasonably priced
products and services of high quality in
an efficient manner. The CAP’s
objectives include providing an
alternative method for physicians to
obtain Part B drugs to administer to
Medicare beneficiaries and reducing
drug acquisition and billing burdens for
physicians; Form Number: CMS–10133
(OMB#: 0938–0955); Frequency:
Reporting—Other, during the bidding
process; Affected Public: Business or
other for-profit; Number of
Respondents: 12; Total Annual
Responses: 12; Total Annual Hours:
480.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
20697
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received at the address below, no
later than 5 p.m. on June 20, 2006.
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development—C, Attention:
Bonnie L. Harkless, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: April 12, 2006.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E6–5833 Filed 4–20–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–2235–NC]
RIN 0938–AO38
State Children’s Health Insurance
Program (SCHIP); Redistribution of
Unexpended SCHIP Funds From the
Appropriation for Fiscal Year 2003;
Additional Allotments To Eliminate
SCHIP Fiscal Year 2006 Funding
Shortfalls; and Provisions for
Continued Authority for Qualifying
States To Use a Portion of Certain
SCHIP Funds for Medicaid
Expenditures
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with comment period.
AGENCY:
SUMMARY: This notice with comment
period describes the procedure for
redistribution of States’ unexpended
Federal fiscal year (FY) 2003 SCHIP
allotments remaining at the end of FY
2005 to those States that fully expended
such allotments. This notice also
announces the application of the
provisions of the Deficit Reduction Act
of 2005 (DRA, Pub. L. 109–171, enacted
on February 8, 2006) concerning the
availability of additional allotments
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 71, Number 77 (Friday, April 21, 2006)]
[Notices]
[Page 20697]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5833]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10193 and CMS-10133]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS) is publishing the following summary of proposed
collections for public comment. Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
1. Type of Information Collection Request: New Collection; Title of
Information Collection: Medicare Clinical Laboratory Services
Competitive Bidding Demonstration Project--Bidding Form; Use: The
Medicare Clinical Laboratory Competitive Bidding Demonstration is
mandated by section 302(b) of the Medicare Prescription Drug,
Improvement and Modernization Act (MMA) of 2003. The purpose of the
demonstration is to determine whether competitive bidding can be used
to provide quality laboratory services at prices below current Medicare
reimbursement rates. The application is to collect information from
organizations that supply clinical laboratory services to Medicare
beneficiaries in the Competitive Bidding Area (CBA). This information
will be used to determine bidding status, winners under the bidding
competition, and the competitively-determined fee schedule for
demonstration tests. The winning laboratories will be selected based on
multiple criteria, including price bid, laboratory capacity, service
area, and quality. Multiple winners are expected in each competitive
acquisition areas; Form Number: CMS-10193 (OMB: 0938-New);
Frequency: Reporting--Other: Once every three years; Affected Public:
Business or other for-profit; Number of Respondents: 80; Total Annual
Responses: 80; Total Annual Hours: 7010.
2. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Competitive
Acquisition Program (CAP) for Medicare Part B Drugs: Vendor Application
and Bid Form; Use: The CAP Vendor Application and Bid Form is a
collection tool which will be used by potential vendors to provide
information related to the characteristics of their company and to
submit their bid prices for CAP drugs. The information collected on the
CAP Vendor Application and Bid Form will be used by CMS during the
bidding evaluation process to evaluate the vendors bid prices, their
credentials, experience and to assess their ability to provide quality
service to physicians and beneficiaries. Competitive bidding is seen as
a means of using the dynamics of the marketplace to provide incentives
for suppliers to provide reasonably priced products and services of
high quality in an efficient manner. The CAP's objectives include
providing an alternative method for physicians to obtain Part B drugs
to administer to Medicare beneficiaries and reducing drug acquisition
and billing burdens for physicians; Form Number: CMS-10133
(OMB: 0938-0955); Frequency: Reporting--Other, during the
bidding process; Affected Public: Business or other for-profit; Number
of Respondents: 12; Total Annual Responses: 12; Total Annual Hours:
480.
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web Site address at https://www.cms.hhs.gov/PaperworkReductionActof1995,
or e-mail your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call
the Reports Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received at the address below,
no later than 5 p.m. on June 20, 2006.
CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development--C, Attention: Bonnie L. Harkless,
Room C4-26-05, 7500 Security Boulevard, Baltimore, Maryland 21244-1850.
Dated: April 12, 2006.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. E6-5833 Filed 4-20-06; 8:45 am]
BILLING CODE 4120-01-P
